Newsweek, October 14, 2017. Will FDA approve this drug despite lack of evidence? Will insurance pay for it?
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Replacing Faulty Heart Devices Costs Medicare $1.5 Billion in 10 Years
New York Times, October 2, 2017. A new report finds 7 types of defective pacemakers cost Medicare billions of dollars and NCHR’s president recommends reporting be required.
Read More »Nearly a Dozen Artificial Turf Fields in DC Failed Last Round of Safety Tests
Fox 5 News, September 18, 2017. 11 artificial turf fields in the District have failed their most recent round of testing, leading to closures and replacements, and igniting another debate over the safety of synthetic turf.
Read More »Streamlined FDA Reviews Fail to Catch Dangerous Glitches in Health Software, Study Finds
STAT News, September 12, 2017. The Food and Drug Administration carefully polices many categories of drugs and devices. But when it comes to software, the agency’s oversight is scanty at best — something that a new study finds is resulting in failure to detect dangerous glitches in software-enabled medical equipment.
Read More »Will Controversial Bill Cure or Kill Patients?
Who What Why, September 7, 2017. Diana Zuckerman, president of the National Center for Health Research, points out that drug companies rely on a three-phase clinical trial process to gain FDA approval for their products. If RTT siphoned off patients with life-threatening illnesses from clinical trials, particularly for trials of medications serving limited populations with rare diseases, drug companies might find it even harder to enroll enough patients to complete them. And health insurers will not pay for drugs that lack FDA approval.
Read More »